Nalaka Kanakaratne, Wahala M.P.B. Wahala, William B. Messer, Hasitha A. Tissera, Aruna Shahani, Nihal Abeysinghe, Aravinda M. de Silva, and Maya Gunasekera1
Author affiliations: Genetech Research Institute, Colombo, Sri Lanka (N. Kanakaratne, M. Gunasekera); University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA (W.M.P.B. Wahala, W.B. Messer, A.M de Silva); Ministry of Health, Colombo (H.A. Tissera, N. Abeysinghe); Apollo Hospital, Colombo (A. Shahani)
Figure 1. A) Dengue cases reported to the Epidemiology Unit, Ministry of Health, Sri Lanka (1981–2005). B) Comparison of monthly reported data for Colombo and Genetech for 2003–2006. Colombo data are based on cases reported to the Ministry of Health by hospitals and clinics within the Colombo Municipal Council. Genetech data are based on the number of PCR-positive cases detected each month.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.